Acumapimod - CAS 836683-15-9
Not Intended for Therapeutic Use. For research use only.
Category:
Inhibitor
Product Name:
Acumapimod
Catalog Number:
836683-15-9
Synonyms:
BCT 197; BCT197A2201;3-(5-amino-4-(3-cyanobenzoyl)-1H-pyrazol-1-yl)-N-cyclopropyl-4-methylbenzamide
CAS Number:
836683-15-9
Description:
Acumapimod is a P38 mitogen-activated protein kinase inhibitor with IC50 value of less than 1 μM for p38α. Phase II clinical trials for the treatment of Chronic obstructive pulmonary disease are on-going.
Molecular Weight:
385.42
Molecular Formula:
C22-H19-N5-O2
Quantity:
Milligrams-Grams
Quality Standard:
In-house standard
COA:
Inquire
MSDS:
Inquire
Canonical SMILES:
Cc1ccc(cc1n2c(c(cn2)C(=O)c3cccc(c3)C#N)N)C(=O)NC4CC4
InChI:
1S/C22H19N5O2/c1-13-5-6-16(22(29)26-17-7-8-17)10-19(13)27-21(24)18(12-25-27)20(28)15-4-2-3-14(9-15)11-23/h2-6,9-10,12,17H,7-8,24H2,1H3,(H,26,29)
InChIKey:
VGUSQKZDZHAAEE-UHFFFAOYSA-N
Targets:
p38 MAPK
Current Developer:
Mereo BioPharma; Novartis

Related p38 MAPK Products


CAS 152121-47-6 SB-203580

SB-203580
(CAS: 152121-47-6)

CAS 869185-85-3 SB 203580 hydrochloride

SB 203580 hydrochloride
(CAS: 869185-85-3)

SB 203580 hydrochloride is a water-soluble form of the potent MAP kinase inhibitor SB 203580. It is a selective inhibitor of p38 mitogen-activated protein kinas...

p38 MAPK-IN-1
(CAS: 1006378-90-0)

p38 MAPK-IN-1, a naphthyridine N-oxide, is a novel potent and selective inhibitor of p38 MAPK and it was found to have proper balance between potency and pharma...

CAS 309913-83-5 Talmapimod hydrochloride

Talmapimod hydrochloride
(CAS: 309913-83-5)

Talmapimod, also known as SCIO-469, is an orally bioavailable, small-molecule, p38 mitogen-activated protein kinase (MAPK) inhibitor with potential immunomodula...

CAS 209410-46-8 VX-745

VX-745
(CAS: 209410-46-8)

VX 745 is a potent and selective inhibitor of p38α mitogen-activated protein (MAP) kinase. VX 745 is a potential anti-inflammatory agents. Studies suggest that ...

CAS 585543-15-3 Losmapimod (GW856553)

Losmapimod (GW856553)
(CAS: 585543-15-3)

Losmapimod is a promising new agent against cardiovascular diseases. This drug works by inhibiting p38 MAP kinases, which play an important role in the developm...

CAS 285983-48-4 Doramapimod

Doramapimod
(CAS: 285983-48-4)

Doramapimod (BIRB 796) is a member of the N-pyrazole-N'-naphthly urea class of p38MAPK inhibitors, which binds to the kinase with both slow association and diss...

CAS 152121-53-4 PD 169316

PD 169316
(CAS: 152121-53-4)

CAS 586379-66-0 PH-797804

PH-797804
(CAS: 586379-66-0)

PH-797804 is a diarylpyridinone inhibitor of p38 mitogen-activated protein (MAP) kinase. PH-797804 exhibited exceptionally high specificity against MAP kinases ...

UPC-K-005

UPC-K-005 is a novel small-molecule inhibitor of a new allosteric site in p38α (IC50 = 13 mcM), which is the binding site for MAPK-activated protein kinase 2 (M...

CAS 193746-75-7 SB-242235

SB-242235
(CAS: 193746-75-7)

SB-242235 is a potent and selective p38 MAP kinase inhibitor with IC50 of 1.0 uM.

CAS 193551-21-2 SB239063

SB239063
(CAS: 193551-21-2)

SB239063 is a potent p38MAPK inhibitor. SB 239063 had an IC(50) of 44 nM for inhibition of recombinant purified human p38alpha. In lipopolysaccharide-stimulated...

CAS 152121-30-7 SB202190

SB202190
(CAS: 152121-30-7)

SB202190, also named FHPI, under the IUPAC name 4-[4-(4-fluorophenyl)-5-pyridin-4-yl-1,3-dihydroimidazol-2-ylidene]cyclohexa-2,5-dien-1-one, is a pyridinyl imid...

AMG 548
(CAS: 864249-60-5)

AMG-548 is a selective p38α inhibitor with Ki value of 0.5nM. It displays >1000-fold selectivity against 36 other kinases, and it can inhibit whole blood LPS-st...

Acumapimod
(CAS: 836683-15-9)

Acumapimod is a P38 mitogen-activated protein kinase inhibitor with IC50 value of less than 1 μM for p38α. Phase II clinical trials for the treatment of Chronic...

CAS 271576-80-8 SD-06

SD-06
(CAS: 271576-80-8)

SD-06 is an inhibitor of p38α (IC50=170 nM).

RPR-200765A Mesylayte
(CAS: 218162-38-0)

RPR-200765A Mesylayte, a potent and selective inhibitor of p38 MAP kinase (IC50 = 50 nM), could exhibit a profile of disease modifying activity in rheumatoid ar...

CHMFL-ABL-053
(CAS: 1808287-83-3)

CHMFL-ABL-053 is a potent and orally available inhibitor of BCR-ABL (IC50 = 70nM) without inhibitory activity against c-KIT kinase that is a common target of BC...

TA-02
(CAS: 1784751-19-4)

TA-02 is a p38 MAPK inhibitor ( IC50 = 20 nM ).

CAS 862507-23-1 LY2228820 dimesylate

LY2228820 dimesylate
(CAS: 862507-23-1)

LY2228820 dimesylate is a highly selective small molecule inhibitor of p38α(IC50=7 nM) and p38β mitogen-activated protein kinases (MAPKs).